Ebola vaccine

Ebola vaccine

C025/0059 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.4MB

Downloadable file size: 14.5MB

Price image Pricing

Please login to use the price calculator


Restrictions: Commercial use requires clearance

Caption: Female vounteer receiving a dose of the investigational NIAID/GSK ebola vaccine. This trial will determine if the vaccine is safe in humans and if it induces an adequate immune response. The vaccine uses a chimpanzee cold virus (chimp adenovirus type 3) to carry the genetic material for an ebola virus protein. The viruses cause ebola virus disease (EVD), a severe and often fatal disease with symptoms including fever, fatigue, muscle aches, vomiting, diarrhoea and haemorrhaging (internal bleeding). It is spread through direct contact with infected bodily fluids. There is no cure for the disease, but three quarters of patients can recover if provided with sufficient medical support. Photographed at the University of Oxford, UK, on 14th November 2014.

Release details: Model release available. Property release not required.

Keywords: 14 november 2014, 2000s, 21st century, adult, biological, biology, bivalent vaccine, cad3-ebo z, candidate vaccine, chimp adenovirus type 3, ebl01, ebola, ebola haemorrhagic fever, ebola hemorrhagic fever, ebola virus, ebola virus disease, ecd, ehf, england, english, experimental, female, hand, immunisation, immunising, immunization, immunizing, immunogenicity, immunological, immunology, injecting, inoculating, inoculation, investigational, laboratory, medical, medicine, monovalent, needle, niaid/gsk ebola vaccine, nurse, pharmacological, pharmacology, phase 1a clinical trial, phial, syringe, trial, two people, uk, united kingdom, university of oxford, vaccinating, vaccination, vaccine, vial, viral, volunteer, woman, zaire ebola viral vector

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.